Search clinical trials for: Doxorubicin

Total 1968 results

Istituto Scientifico Romagnolo per lo Studio e...

Terminated

A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer (CAELYX)

HER-2 Positive Breast Cancer | Malignant Neoplasm of Breast

Italy
M.D. Anderson Cancer Center

Completed

Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative

Invasive Breast Carcinoma | Triple-Negative Breast Carcinoma

United States
Peking University People's Hospital

Recruiting

Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells

Malignant Bone Tumor

China
Ruhr University of Bochum

Completed

Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer

Recurrent Ovarian Cancer

Germany
Gem Pharmaceuticals

Completed

Safety Study of GPX-150 in Patients With Solid Tumors

Advanced Solid Tumors - Phase 1 Population

United States
Heidelberg University
University Hospital Tuebingen; SLK Kliniken Heilbronn GmbH

Unknown

TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients

Stage IV Melanoma Patients With Unresectable Liver Metastases

Germany
The Netherlands Cancer Institute
Bristol-Myers Squibb

Recruiting

Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients (TONIC-2)

Metastatic Breast Cancer

Netherlands
Italian Sarcoma Group

Active, not recruiting

Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor (STRADA)

Solitary Fibrous Tumors

Italy
Gem Pharmaceuticals

Completed

Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma

Soft Tissue Sarcoma

United States
Hospital San Carlos, Madrid
UNC Lineberger Comprehensive Cancer Center

Completed

Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer

Breast Cancer

Spain
Second Affiliated Hospital, School of Medicine,...

Recruiting

AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer

Breast Cancer | Chemotherapeutic Toxicity

China
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC

Recruiting

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

Hodgkin Lymphoma | Relapsed or Refractory Hodgkin Lymphoma

United States
Oslo University Hospital
Bristol-Myers Squibb; Helse Stavanger HF; Sorlandet Hospital HF; Cliniques universitaires... and other collaborators

Completed

Phase IIb Study Evaluating Immunogenic Chemotherapy Combined With Ipilimumab and Nivolumab in Breast Cancer (ICON)

Breast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor

Norway, Belgium
Oslo University Hospital
Karolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger... and other collaborators

Completed

Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple-negative Breast Cancer (ALICE)

Triple Negative Breast Cancer | Cancer, Breast

Norway, Denmark
ImmunoGen, Inc.
Gynecologic Oncology Group; European Network of Gynaecological Oncological...

Active, not recruiting

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (MIRASOL)

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer

United States, Canada, Germany, China, France, Korea, Republic of, Belgium, United Kingdom, Serbia, Spain, Australia, Israel, Italy, Taiwan, Czechia, Bulgaria, Netherlands, Portugal, Poland, Russian Federation, Ukraine
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Breast Cancer

Breast Cancer

United States, Canada
Virginia Commonwealth University

Completed

Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers

Sarcoma | Breast Cancer | Gynecologic Cancer | Gastrointestinal Cancer | Genitourinary Cancer

United States
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer (MITO27)

Ovarian Cancer

Italy
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer

Breast Cancer

United States, South Africa
Roswell Park Cancer Institute

Completed

Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Sanofi

Completed

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

Neoplasm Malignant

United States
WiSP Wissenschaftlicher Service Pharma GmbH
ClinAssess GmbH

Unknown

Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer (PROVE)

Ovarian Cancer

Germany
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer

Breast Cancer

United States, Canada, Puerto Rico
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Lung Cancer

France
Bristol-Myers Squibb
Eisai Inc.

Recruiting

A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Neoplasms, Ovarian

Australia, United States, Korea, Republic of, Chile, Belgium, Italy, Spain, Israel, Japan
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter

United States
Northwestern University
National Cancer Institute (NCI)

Completed

Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer

Breast Cancer

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Cologne

Active, not recruiting

Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma (B-CAP)

Hodgkin Lymphoma

Germany
Vilnius University
National Cancer Institute (NCI); Vilnius University Hospital Santaros Klinikos

Recruiting

PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer

Gastric Cancer | Peritoneal Carcinomatosis

Lithuania
University Hospital, Basel, Switzerland

Completed

Anti-EGFR Immunoliposomes in Solid Tumors

Solid Tumors

Switzerland
King Faisal Specialist Hospital & Research Center

Completed

Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer

Breast Cancer
Gilead Sciences

Terminated

A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma

Multiple Myeloma

United States
Sutro Biopharma, Inc.
GOG Foundation; European Network of Gynaecological Oncological Trial Groups... and other collaborators

Recruiting

REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1

Ovarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Cancer

United States, Australia, Korea, Republic of, Israel, Singapore, Canada
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer. (MITO29)

Recurrent, Platinum-resistant Ovarian Cancer

Italy
Roswell Park Cancer Institute

Terminated

Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Liver Cancer

United States
Amgen

Unknown

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Pain | Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer

United States
National Cancer Institute (NCI)

Recruiting

Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, (DURVA+ Study)

Malignant Solid Neoplasm

United States
Fondazione Michelangelo

Terminated

R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma

Hodgkin Lymphoma

United States, Italy
Peking University International Hospital
Peking University First Hospital; Beijing Friendship Hospital; Shanghai Zhongshan... and other collaborators

Enrolling by invitation

Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma (NATARS)

Retroperitoneal Sarcoma

China
Northwestern University
National Cancer Institute (NCI)

Completed

Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
ImmunityBio, Inc.

Withdrawn

QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine (TNBC)

Triple Negative Breast Cancer (TNBC)

United States
North Eastern German Society of Gynaecological...

Completed

Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer

Ovarian Cancer
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel (NEUGR-003)

Chemotherapy-induced Neutropenia

Bulgaria, Romania, Russian Federation, Serbia, Ukraine
Seoul National University Hospital

Unknown

Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma

Carcinoma, Non-Small-Cell Lung

Korea, Republic of
Columbia University

Terminated

A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers (HIPEC)

Fallopian Tube Cancer | Recurrent Ovarian Cancer

United States
Janssen Research & Development, LLC

Completed

A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer

Neoplasms

United States, Spain, Canada, Belgium
Medifocus, Inc.

Unknown

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors (Medifocus301)

Breast Cancer

United States, Canada

Search clinical trials for: Doxorubicin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations